The post-marketing safety of venlafaxine: a real-world two-decade pharmacovigilance study using the FAERS database
This pharmacovigilance analysis systematically identified significant safety signals associated with venlafaxine. The findings provide important evidence to support safer clinical use of venlafaxine and may assist in optimizing individualized therapeutic decisions in practice.
Authors
- Santosh Chokkakula (ORCID: https://orcid.org/0000-0002-1961-4454)
- Bo Yang (ORCID: https://orcid.org/0000-0003-0052-048X)
- Abeer A. Al-Masri
- Bommireddy Naveen
- Hualiang Yang
- Yiquan Zhang
Institutions
- Gachon University (KR)
- Chungbuk National University (KR)
- King Saud University (SA)
- Krirk University (TH)
- National University College (PR)
- Tianjin Central Hospital of Gynecology Obstetrics (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/fphar.2026.1737113
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Saud University